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Background
Maturity-onset Diabetes of the Young (MODY; OMIM#
606391) is often related to a single gene mutation and
characterized by dominant inheritance and non-insulin-
dependent DM with a young age at diagnosis (Fajans
et al., 2001). The most frequent subtype, MODY2, Results
from SNPs in the glucokinase gene (Osback et al., 2009).
Mapped to human chromosome 7p15.3-p15.1, the GCK
gene consists of 10 exons and roughly 45 Kb. More than
600 SNPs were reported to this gene and among those,
around 200 are related to the disease (Osback et al., 2009).
Objective
We propose screening the GCK gene by DNA sequencing
from one 83-year-old volunteer with a MODY2 diagnostic
hypothesis.
Materials and methods
Informed consent (IC) was obtained and the study was
approved by the ethics committee from our institution
(CAAE: 40094114.0.0000.5016/License 923.744). The total
DNA was extracted using a standard protocol to the blood
extraction (PuriLink® Genomic DNA Kit-InvitrogenTM
by Thermo). The primers used in this study were adapted
from Mota and colleagues (2011). The PCR was per-
formed by Go®Taq Flexi DNA Polymerase kit (Promega)
following the manufacturer's instructions. The amplicons
sequencing was carried out using the Big Dye® Termina-
tor v3.1 Cycle Sequencing (Applied BiosystemsTM by Life
Technologies) and determined in an ABI 3500XL instru-
ment (Applied BiosystemsTM). The sequences were ana-
lyzed using Lasergene® SeqMan ProTM for MacOs,
version 11.2.1 (DNASTAR®) and were compared with the
GenBank human genomic plus transcript database using
the BLAST tool (Zhang et al., 2000).
Results
In this study we were able, so far, to access information
from 6 exons (including the three isoforms of exon 1, and
from exon 2 to 6). The coding sequences of all exons were
identical to those in the INSDC database. However, one
SNP (T>C) was identified immediately after the exon 6,
i. e., in the exon/intron junction, changing the consensus
GT to GC (Fig. 1). To date such mutation, as presented in
this study, were not reported to the MODY disease, how-
ever, it is thought that mutation within splicing site may
be implicated in roughly 10% of the total disease caused
by mutations (Ward and Cooper, 2010).
Conclusion
In this study we reported one new mutation within the
splicing site, downstream to the exon 6 of the GCK gene.
In the future perspectives we will investigate whether this
mutation is or not related to the MODY2 disease.
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Figure 1 Exon 6 sequence is represented in codon-type division. Gray boxes are consensus sequence of the splicing site. NM_033507.1 is the
access number to the sequence. Proband: this study. Y means C or T on that position.
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